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 The more recent strategies in medicinal chemistry involve the pharmacokinetic profiling of new molecules as soon as possible 
in the development pipeline with the clear aim to develop only drug-like compounds.1
 Among the pharmacokinetic failures, unsuitable metabolic fates represent the most frequent and impeding problems during 
clinical trials.
 Hence, much effort is now devoted to in silico models to predict metabolic stability and metabolites. Such models are well 
known for cytochromes P450 and various conjugating enzymes, and they enjoy a relative success. 
 In contrast, little has been done to predict the hydrolyzing activity of human esterases, although these play a key role in the 
hydrolytic metabolism of xenobiotics and in the activation of most prodrugs.
 Among the esterase enzymes, the carboxylesterases2 play a pivotal role in the hydrolysis of a variety of drugs or prodrugs 
containing ester, amide or carbamate functions to the respective free acids. CES isozymes can be classified into five groups 
(CES1-CES5) and the majority of CESs, which have been identified, belong to the CES1 or CES2 family.
 They are members of the serine hydrolase family (α,β hydrolase fold). The catalytic triad is composed by a serine (Ser221 in 
hCES1) which contacts the substrates, plus two residues (His468 and Glu354 in hCES1) which increase the polarity of Ser221.
 CES1 and CES2 differ from their specificity. CES1 hydrolyzes substrates with small alcohol groups and large acyl groups; 
CES2 recognizes substrates with large alcohols and small acyls. The CES2 specificity is much more constrained.
Aim of this work was to develop a computational approach able to predict and rationalize the hydrolysis of new 
chemical entities by the human carboxylesterase hCES1.
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The congruity of the obtained complexes and the correlations between docking scores and enzymatic data 
afford an encouraging validation for the described docking results which can be used to predict the 
hydrolytic metabolism of new molecules. In detail, the simulations reveal that (i) MLPInS scores proved 
successful to account for lipophilicity in binding; (iii) an optimal CES1 substrate should possess the alcohol 
group smaller and more polar; (iii) CES1 prefers neutral or anionic substrates, while the cationic ligands 
can behave as inhibitors; (iv) the product egress can be simulated by simple all-atoms MD runs.
Docking analyses: unveiling the CES1 catalytic site
Basic substrates and CES1 activity 
the case of heroin hydrolysis4
Accounting for lipophilicity in docking: the MLPInS score3Background
Aim of the work
Conclusions
Choice of an optimal CES1 structure for docking
 Up to now, 13 experimental structures for hCES1 have been deposited in PDB, but the apo-enzyme has not been yet resolved.
 The structures of the enzyme in complex with non competitive and covalently bound inhibitors were discarded.
 The similarity between the nine remaining hCES1 structures was analyzed by the pair-wise rmsd values.
1YAJ: hCES1-benzoate        1MX9: hCES1-Naloxone
The structures are very similar and the main differences concern the 
catalytic cavity. The greatest rmsd value is afforded by CES1 in 
complex with benzoate (1YAJ), an enzymatic product which derives 
from degradation of the benzil inhibitor, versus CES1 in complex 
with naloxone methiodide (1MX9), a stable analogue of heroin.
1YAJ may represent the enzyme in the apo state 
since the small size of the enzymatic product cannot 
markedly distort the catalytic cavity during its egress.
1MX9 may correspond to the holo state since the 
enzyme is accommodating a large substrate and its 
binding cavity should be enlarged enough to 
encompass any substrate.
Docking analyses involved both experimental structures (1YAJ and 
1MX9) as they should represent two different states of the enzyme. 
The training set was then used to uncover which CES1 structure 
affords the best predictions.
 Selecting best docking conditions (training set)
(i.e. CES structure and ionization state)
 Assessing statistical robustness (test set)
 Docking simulations were performed considering the 11 basic substrates included in training set both neutral and ionized.
 Since the study initially involved two CES1 structures, four sets of docking simulations were globally carried out. 
 The four best relationships were derived including constantly 2 variables taken from docking scores and/or ligand properties.
 Obtained relationships unveil that (i) docking analyses performed using 1YAJ structure afford always better correlations and 
(ii) in both cases the neutral substrates correlate better than the ionized forms suggesting that the formers are more probably 
involved in the enzyme recognition. The Eq. 2 was thus exploited to investigate its predictivity power.
Eq. 1: Ionized basic substrates
pKm = -0.0073 PSA – 0.34 MLPInS + 4.39
n = 25; r2 = 0.61; q2 = 0.49; SE = 0.72; F = 17.52
pKm = -0.38 distSer221 – 1.66 MLPInS + 4.18
n = 25; r2 = 0.85; q2 = 0.73; SE = 0.49; F = 64.06
Eq. 2: Neutral basic substratesCES1
1YAJ
Eq. 3: Ionized basic substrates
pKm = -0.0067 PSA – 0.12 MLPInS + 4.22
n = 25; r2 = 0.38; q2 = 0.32; SE = 0.92; F = 6.62
pKm =0.0039 Volume – 1.29 MLPInS + 1.76
n = 25; r2 = 0.64; q2 = 0.51; SE = 0.65; F = 19.38
Eq. 4:  Neutral basic substratesCES1
1MX9
Is the Eq. 2 truly robust ? Can Eq. 2 predict external test set ?  
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pKm = -0.38 distSer221 – 1.66 MLPInS + 4.18
n = 25; r2 = 0.85; q2 = 0.73; SE = 0.49; F = 64.06
Eq. 2
The plot shows that there are not clear differences 
between training (squares) and test (triangles) 
substrates as confirmed by good relation between 
experimental and computed values in test set.
Test set:
pKm(pred) = 1.09 pKm(exp) - 0.41 
n=15; r2=0.75; s=0.50; F=39.40 
Considerations:
 distSer221 encodes the ability of a ligand to assume a pose 
conducive to the catalysis. 
 All relations include the MLPInS score, confirming that:
• CES1 recognition is driven by hydrophobic contacts.
• MLPInS is fruitful to account for lipophilicity in binding.
 In general, the lipophilicity plays a crucial role in ligand recognition, but little has been done to quantify specifically its effect 
in docking scores.
 In particular, the substrate recognition by hCES1 appears largely driven by hydrophobic contacts emphasizing the need for 
an appropriate and specific lipophilic score.
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ƒa and ƒb = Broto’s atomic increments.
fct(rab) = Distance function. Many functions were tested.
Best results are obtained by fct(rab) = (rab)3
The sums involve all ligand (p) and enzyme (m) atoms.
Globally MLPInS encodes:
- Hydrophobic contacts (ƒa and ƒb > 0)
- Polar interactions (ƒa and ƒb < 0)
- Repulsive forces (otherwise)
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• The hCES1 cavity is completely lined by hydrophobic residues.
• The negative residues play a key role in product egress.
• The cavity for alcohols is: smaller, less flexible and slightly more polar.
Legend for residues:
Green = apolar
Red = negative
Blue = H-bonding
The differences between the two sub-cavities 
reflect on the average properties for alcohol 
and acyl groups of the substrates.
To explore the influence of ionization on CES1 activity, the 
stability of the complexes of heroin, 6-O-acetylmorphine and 
morphine in both ionization states was analyzed by 5-ns MD runs 
All plots report the distance between Ser221 and ester group. 
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Morphine’s simulations Considerations:
The two substrates remain in the catalytic site 
irrespective of the ionization state.
The neutral form of morphine leaves the site and 
allows the catalytic turn-over.
The ionized form of morphine remains docked into 
the site behaving as competitive inhibitor.
The reasonable behavior of simulated complexes 
affords an encouraging validation of their stability.
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Predicting the CES1 activity
The cross-relation between MLPInS
and log P is very low
